Editorial Board for section 'Pharmacology'
- Anesthesiology Section
- Brain Injury Section
- Clinical Laboratory Medicine Section
- Cardiology Section
- Cardiovascular Medicine Section
- Clinical Neurology Section
- Mental Health Section
- Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine Section
- Dermatology Section
- Endocrinology & Metabolism Section
- Epidemiology & Public Health Section
- Emergency Medicine Section
- Gastroenterology & Hepatopancreatobiliary Medicine Section
- Hematology Section
- Intensive Care Section
- Immunology Section
- Infectious Diseases Section
- Nephrology & Urology Section
- Nuclear Medicine & Radiology Section
- Oncology Section
- Obstetrics & Gynecology Section
- Ophthalmology Section
- Orthopedics Section
- Otolaryngology Section
- Pharmacology Section
- Respiratory Medicine Section
- Reproductive Medicine & Andrology Section
- Sports Medicine Section
- Dentistry, Oral Surgery and Oral Medicine Section
- Vascular Medicine Section
- General Surgery Section
- Clinical Rehabilitation Section
- Clinical Guidelines Section
- Clinical Research Methods Section
- Clinical Pediatrics Section
- Geriatric Medicine Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
West China School of Medicine, West China Hospital of Sichuan University, Chengdu, China
Interests: cancer pharmacology, targeted drug delivery and precison oncology
Interests: cancer pharmacology, targeted drug delivery and precison oncology
Dr. Zhijie Xu
Section Board Member
Department of Pathology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, China
Interests: anti-tumor pharmacology; programmed cell death; non-coding RNA; native compounds
Special Issues, Collections and Topics in MDPI journals
Interests: anti-tumor pharmacology; programmed cell death; non-coding RNA; native compounds
Special Issues, Collections and Topics in MDPI journals
1. Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
2. Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha 410078, China
Interests: clinical pharmacology; personalized medicine; precision medicine; pharmacogenomics; pharmacogenetics
2. Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha 410078, China
Interests: clinical pharmacology; personalized medicine; precision medicine; pharmacogenomics; pharmacogenetics
College of Pharmacy, Chongqing Medical University, Chongqing, China
Interests: natural metabolite-based immunomodulator research; R&D of key processes for biological preparations; quality research of biological products such as vaccines and antibodies; R&D and improvement of adjuvant preparation process and R&D of new adjuvants
Interests: natural metabolite-based immunomodulator research; R&D of key processes for biological preparations; quality research of biological products such as vaccines and antibodies; R&D and improvement of adjuvant preparation process and R&D of new adjuvants
